{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:08:21Z","timestamp":1793837301502,"version":"4.6.1"},"reference-count":609,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T00:00:00Z","timestamp":1643500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["2R01AG039621"],"award-info":[{"award-number":["2R01AG039621"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.pharmthera.2022.108119","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T18:23:50Z","timestamp":1643567030000},"page":"108119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"special_numbering":"C","title":["Blood-brain barrier leakage in Alzheimer\u2019s disease: From discovery to clinical relevance"],"prefix":"10.1016","volume":"234","author":[{"given":"Geetika","family":"Nehra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika M.S.","family":"Hartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2022.108119_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood-brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0010","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1523\/JNEUROSCI.1064-09.2009","article-title":"Cognitive decline in Alzheimer\u2019s disease is associated with selective changes in calcineurin\/NFAT signaling","volume":"29","author":"Abdul","year":"2009","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0015","first-page":"163","article-title":"Fibrin mechanisms and functions in nervous system pathology","volume":"4","author":"Adams","year":"2004","journal-title":"Molecular Interventions"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0020","first-page":"335","article-title":"Drug and xenobiotic biotransformation in the blood-brain barrier: a neglected issue","volume":"8","author":"Agundez","year":"2014","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroscience.2018.05.002","article-title":"Characterization of impaired cerebrovascular structure in APP\/PS1 mouse brains","volume":"385","author":"Ahn","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0304-3940(92)90065-F","article-title":"Thrombin accumulation in brains of patients with Alzheimer\u2019s disease","volume":"146","author":"Akiyama","year":"1992","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0035","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1021\/acschemneuro.9b00175","article-title":"Oleocanthal-rich extra-virgin olive oil restores the blood-brain barrier function through NLRP3 inflammasome inhibition simultaneously with autophagy induction in TgSwDI mice","volume":"10","author":"Al Rihani","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0040","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3233\/JAD-190849","article-title":"Granisetron alleviates Alzheimer\u2019s disease pathology in TgSwDI mice through calmodulin-dependent protein kinase II\/cAMP-response element binding protein pathway","volume":"72","author":"Al Rihani","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0022-510X(83)90157-0","article-title":"Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia","volume":"60","author":"Alafuzoff","year":"1983","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF00693782","article-title":"Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study","volume":"73","author":"Alafuzoff","year":"1987","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0055","first-page":"1129","article-title":"\u00dcber einen eigenartigen schweren ErkrankungsprozeB der Hirnrinde","volume":"23","author":"Alzheimer","year":"1906","journal-title":"Neurologisches Centralblatt."},{"key":"10.1016\/j.pharmthera.2022.108119_bb0060","first-page":"146","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allgemeine Zeitschrift fur Psychiatrie und Psychisch-gerichtliche Medizin."},{"key":"10.1016\/j.pharmthera.2022.108119_bb0070","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","article-title":"Incidence and predictors of seizures in patients with Alzheimer\u2019s disease","volume":"47","author":"Amatniek","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0075","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2021.15286","article-title":"Representativeness of participants eligible to be enrolled in clinical trials of aducanumab for Alzheimer disease compared with medicare beneficiaries with alzheimer disease and mild cognitive impairment","volume":"326","author":"Anderson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0080","doi-asserted-by":"crossref","DOI":"10.1089\/pop.2021.0189","article-title":"Aducanumab fails to produce efficacy results yet obtains US Food and Drug Administration approval","author":"Angelo","year":"2021","journal-title":"Population Health Management"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.jnen.0000196133.74087.cb","article-title":"Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain","volume":"65","author":"Arai","year":"2006","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature09613","article-title":"Glial and neuronal control of brain blood flow","volume":"468","author":"Attwell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0095","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jnnp.67.4.558","article-title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","volume":"67","author":"Babic","year":"1999","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-328X(98)00066-7","article-title":"The NF-kappaB\/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation","volume":"57","author":"Bales","year":"1998","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2012.07.010","article-title":"The vascular factor in Alzheimer\u2019s disease: a study in Golgi technique and electron microscopy","volume":"322","author":"Baloyannis","year":"2012","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0110","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/brain\/awx003","article-title":"MRI-visible perivascular space location is associated with Alzheimer\u2019s disease independently of amyloid burden","volume":"140","author":"Banerjee","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0115","doi-asserted-by":"crossref","first-page":"B601","DOI":"10.1093\/gerona\/55.12.B601","article-title":"Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse","volume":"55","author":"Banks","year":"2000","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2007.05.005","article-title":"Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer\u2019s disease: an age-related selective uptake with reversal of learning impairment","volume":"206","author":"Banks","year":"2007","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0197-4580(01)00220-2","article-title":"Regional transport of TNF-alpha across the blood-brain barrier in young ICR and young and aged SAMP8 mice","volume":"22","author":"Banks","year":"2001","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-#","article-title":"Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier","volume":"208","author":"Barber","year":"1997","journal-title":"Developmental Dynamics"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0140","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/mrm.25793","article-title":"Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI","volume":"75","author":"Barnes","year":"2016","journal-title":"Magnetic Resonance in Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JAD-180755","article-title":"Lipopolysaccharide induced opening of the blood brain barrier on aging 5XFAD mouse model","volume":"67","author":"Barton","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archneur.60.3.393","article-title":"White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study","volume":"60","author":"Bartzokis","year":"2003","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0155","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/acschemneuro.7b00101","article-title":"Crocus sativus extract tightens the blood-brain barrier, reduces amyloid beta load and related toxicity in 5XFAD mice","volume":"8","author":"Batarseh","year":"2017","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jnutbio.2017.12.006","article-title":"Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-beta load and related toxicity in a mouse model of Alzheimer\u2019s disease","volume":"55","author":"Batarseh","year":"2018","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0165","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.119.13187","article-title":"Combinatorial treatment using umbilical cord perivascular cells and abeta clearance rescues vascular function following transient hypertension in a rat model of Alzheimer disease","volume":"74","author":"Bazzigaluppi","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0170","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1523\/JNEUROSCI.4936-10.2011","article-title":"Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy","volume":"31","author":"Beckmann","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0175","doi-asserted-by":"crossref","first-page":"8453","DOI":"10.1523\/JNEUROSCI.23-24-08453.2003","article-title":"Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer\u2019s disease","volume":"23","author":"Beckmann","year":"2003","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0180","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2119\/2007-00034.Bellucci","article-title":"Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease","volume":"13","author":"Bellucci","year":"2007","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0185","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.neurobiolaging.2013.04.023","article-title":"Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer\u2019s disease","volume":"34","author":"Benedictus","year":"2013","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0190","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ajpath.2017.03.011","article-title":"Enhanced Tau Aggregation in the Presence of Amyloid beta","volume":"187","author":"Bennett","year":"2017","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0197-4580(00)00121-4","article-title":"Agrin and microvascular damage in Alzheimer\u2019s disease","volume":"21","author":"Berzin","year":"2000","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0200","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0024-3205(99)00349-5","article-title":"As human pial arteries (internal diameter 200-1000 microm) get smaller, their wall thickness and capacity to develop tension relative to their diameter increase","volume":"65","author":"Bevan","year":"1999","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuron.2015.09.036","article-title":"Lack of widespread BBB disruption in Alzheimer\u2019s disease models: focus on therapeutic antibodies","volume":"88","author":"Bien-Ly","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0210","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0215","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.neurobiolaging.2013.10.072","article-title":"Regional white matter hyperintensities: aging, Alzheimer\u2019s disease risk, and cognitive function","volume":"35","author":"Birdsill","year":"2014","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023789","article-title":"Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer\u2019s disease","volume":"6","author":"Biron","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0225","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-2011-110566","article-title":"Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease","volume":"27","author":"Bjerke","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/neur.1995.0023","article-title":"Cerebrospinal fluid \u201cneuronal thread protein\u201d comes from serum by passage over the blood-brain barrier","volume":"4","author":"Blennow","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00002093-199040200-00002","article-title":"Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type","volume":"4","author":"Blennow","year":"1990","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1600-0404.1991.tb04675.x","article-title":"White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors","volume":"83","author":"Blennow","year":"1991","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0245","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-160023","article-title":"Monitoring Blood-Brain Barrier Integrity Following Amyloid-beta Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model","volume":"54","author":"Blockx","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0250","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3233\/JAD-180367","article-title":"Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer\u2019s Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer\u2019s Disease","volume":"66","author":"Boespflug","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-510X(02)00289-7","article-title":"Microvascular damage and platelet abnormalities in early Alzheimer\u2019s disease","volume":"203-204","author":"Borroni","year":"2002","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.brainresbull.2018.03.001","article-title":"Age-dependent changes at the blood-brain barrier. A Comparative structural and functional study in young adult and middle aged rats","volume":"139","author":"Bors","year":"2018","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0265","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acs.molpharmaceut.8b00870","article-title":"Transferrin receptor-mediated uptake at the blood-brain barrier is not impaired by Alzheimer's disease neuropathology","volume":"16","author":"Bourassa","year":"2019","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0270","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12599","article-title":"Brain mural cell loss in the parietal cortex in Alzheimer\u2019s disease correlates with cognitive decline and TDP-43 pathology","author":"Bourassa","year":"2020","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0275","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.neuropharm.2009.01.006","article-title":"Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer\u2019s disease","volume":"56","author":"Bourasset","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0280","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/01.wnl.0000262031.18018.1a","article-title":"Blood-brain barrier impairment in Alzheimer disease: stability and functional significance","volume":"68","author":"Bowman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0285","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neuroimage.2006.05.055","article-title":"Expression mapping of tetracycline-responsive prion protein promoter: digital atlasing for generating cell-specific disease models","volume":"33","author":"Boy","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0290","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-2010-091471","article-title":"GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice","volume":"21","author":"Boyd","year":"2010","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0295","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0300","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1750-1326-7-58","article-title":"The isotropic fractionator provides evidence for differential loss of hippocampal neurons in two mouse models of Alzheimer\u2019s disease","volume":"7","author":"Brautigam","year":"2012","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0305","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","article-title":"Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial","volume":"7","author":"Breitner","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0310","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.neurobiolaging.2015.06.028","article-title":"Cerebral amyloid angiopathy and its co-occurrence with Alzheimer\u2019s disease and other cerebrovascular neuropathologic changes","volume":"36","author":"Brenowitz","year":"2015","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0315","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/NEN.0000000000000124","article-title":"Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people","volume":"73","author":"Bridges","year":"2014","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0320","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbrc.2004.12.123","article-title":"Hypoxia\/aglycemia alters expression of occludin and actin in brain endothelial cells","volume":"327","author":"Brown","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0325","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-2012-120364","article-title":"High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer\u2019s disease","volume":"31","author":"Brundel","year":"2012","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0330","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neurobiolaging.2005.12.003","article-title":"Vessel ultrastructure in APP23 transgenic mice after passive anti-Abeta immunotherapy and subsequent intracerebral hemorrhage","volume":"28","author":"Burbach","year":"2007","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0335","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1148\/radiol.14140245","article-title":"Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior","volume":"273","author":"Burgess","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0340","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2014.07.051","article-title":"Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer\u2019s disease using two-photon microscopy","volume":"192","author":"Burgess","year":"2014","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0345","doi-asserted-by":"crossref","first-page":"S469","DOI":"10.3233\/JAD-179912","article-title":"Perspectives on oxidative stress in Alzheimer\u2019s disease and predictions of future research emphases","volume":"64","author":"Butterfield","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0350","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4062\/biomolther.2019.076","article-title":"Spinosin attenuates Alzheimer\u2019s disease-associated synaptic dysfunction via regulation of plasmin activity","volume":"28","author":"Cai","year":"2020","journal-title":"Biomolecules & Therapeutics (Seoul)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0355","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","article-title":"Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid","volume":"96","author":"Calhoun","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0360","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/jpet.107.127035","article-title":"Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat","volume":"323","author":"Candelario-Jalil","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0365","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1523\/JNEUROSCI.3337-11.2011","article-title":"Adenosine receptor signaling modulates permeability of the blood-brain barrier","volume":"31","author":"Carman","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0370","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-0270(96)00121-5","article-title":"Overexpression of growth-associated proteins in the neurons of adult transgenic mice","volume":"71","author":"Caroni","year":"1997","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0375","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/ars.2011.3895","article-title":"Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy","volume":"15","author":"Carrano","year":"2011","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0380","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/jnp.10.1.78","article-title":"Blood-brain barrier integrity in Alzheimer\u2019s disease patients and elderly control subjects","volume":"10","author":"Caserta","year":"1998","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0385","doi-asserted-by":"crossref","first-page":"257","DOI":"10.14336\/AD.2017.0112","article-title":"Cerebral microvascular accumulation of Tau Oligomers in Alzheimer\u2019s disease and related tauopathies","volume":"8","author":"Castillo-Carranza","year":"2017","journal-title":"Aging and Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0390","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00005072-199606000-00004","article-title":"Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer\u2019s disease and Down\u2019s syndrome","volume":"55","author":"Cataldo","year":"1996","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0395","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuroscience.2021.08.003","article-title":"Magnetic resonance imaging of blood-brain barrier permeability in Dementia","volume":"474","author":"Chagnot","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0400","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/JAD-2011-101959","article-title":"Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease","volume":"25","author":"Chalbot","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0405","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ACO.0b013e328328d1b6","article-title":"The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness","volume":"22","author":"Chappell","year":"2009","journal-title":"Current Opinion in Anaesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0410","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ptr.2122","article-title":"Amelioration of early cognitive deficits by aged garlic extract in Alzheimer\u2019s transgenic mice","volume":"21","author":"Chauhan","year":"2007","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0415","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/jnr.20298","article-title":"Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Abeta antibody into the third ventricle of TgCRND8 mice","volume":"78","author":"Chauhan","year":"2004","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0420","first-page":"2685","article-title":"Ezetimibe protects against spinal cord injury by regulating autophagy and apoptosis through inactivation of PI3K\/AKT\/mTOR signaling","volume":"12","author":"Chen","year":"2020","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0425","doi-asserted-by":"crossref","first-page":"23818","DOI":"10.1074\/jbc.M701078200","article-title":"Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models","volume":"282","author":"Cheng","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0430","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/FJC.0000000000000575","article-title":"Relationship of anticoagulant therapy with cognitive impairment among patients with atrial fibrillation: A meta-analysis and systematic review","volume":"71","author":"Cheng","year":"2018","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0435","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1093\/hmg\/ddz045","article-title":"A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss","volume":"28","author":"Chiquita","year":"2019","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0440","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1074\/jbc.M100710200","article-title":"Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695","volume":"276","author":"Chishti","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0445","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/016173460803000304","article-title":"Noninvasive and transient blood-brain barrier opening in the hippocampus of Alzheimer\u2019s double transgenic mice using focused ultrasound","volume":"30","author":"Choi","year":"2008","journal-title":"Ultrasonic Imaging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0450","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1038\/s41467-020-17218-0","article-title":"NMDAR-mediated modulation of gap junction circuit regulates olfactory learning in C. elegans","volume":"11","author":"Choi","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0455","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1096\/fj.201901318R","article-title":"Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology","volume":"34","author":"Choi","year":"2020","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0460","doi-asserted-by":"crossref","first-page":"349","DOI":"10.17219\/acem\/131216","article-title":"Cerebral small vessel disease: A review","volume":"30","author":"Chojdak-Lukasiewicz","year":"2021","journal-title":"Advances in Clinical and Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0465","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/156720508785132334","article-title":"Structural changes in Alzheimer's disease brain microvessels","volume":"5","author":"Christov","year":"2008","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0470","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/jth.13340","article-title":"Hyperhomocysteinemia exacerbates Alzheimer\u2019s disease pathology by way of the beta-amyloid fibrinogen interaction","volume":"14","author":"Chung","year":"2016","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0475","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/sj.jid.5700670","article-title":"Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations","volume":"127","author":"Clark","year":"2007","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0480","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jacc.2019.07.081","article-title":"Long-term dabigatran treatment delays Alzheimer\u2019s disease pathogenesis in the TgCRND8 mouse model","volume":"74","author":"Cortes-Canteli","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0485","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neurobiolaging.2014.10.030","article-title":"Fibrin deposited in the Alzheimer\u2019s disease brain promotes neuronal degeneration","volume":"36","author":"Cortes-Canteli","year":"2015","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0490","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3233\/JAD-150096","article-title":"Epileptic prodromal Alzheimer's disease, a retrospective study of 13 new cases: expanding the spectrum of Alzheimer's disease to an epileptic variant?","volume":"52","author":"Cretin","year":"2016","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0495","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1385\/MN:23:2-3:121","article-title":"Vascular growth factors in cerebral ischemia","volume":"23","author":"Croll","year":"2001","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0500","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/humu.22117","article-title":"Locus-specific mutation databases for neurodegenerative brain diseases","volume":"33","author":"Cruts","year":"2012","journal-title":"Human Mutation"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0505","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","article-title":"Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer\u2019s disease mouse models","volume":"22","author":"Cruz Hernandez","year":"2019","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0510","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5853\/jos.2017.02922","article-title":"Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies","volume":"20","author":"Cuadrado-Godia","year":"2018","journal-title":"Journal of Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0515","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/00001756-199705260-00033","article-title":"Perivascular astrocytes within Alzheimer\u2019s disease plaques","volume":"8","author":"Cullen","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0520","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.jcbfm.9600155","article-title":"Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex","volume":"25","author":"Cullen","year":"2005","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0525","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.neurobiolaging.2005.10.016","article-title":"Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages","volume":"27","author":"Cullen","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0530","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer's disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0535","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0540","first-page":"515","article-title":"Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys)","volume":"63","author":"D\u2019Angelo","year":"2013","journal-title":"Comparative Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0545","doi-asserted-by":"crossref","first-page":"20296","DOI":"10.1074\/jbc.M312946200","article-title":"Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid beta-protein precursor","volume":"279","author":"Davis","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0550","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.neurobiolaging.2005.05.031","article-title":"Deficient cerebral clearance of vasculotropic mutant Dutch\/Iowa Double A beta in human A betaPP transgenic mice","volume":"27","author":"Davis","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0555","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/glia.22960","article-title":"Into rather unexplored terrain-transcellular transport across the blood-brain barrier","volume":"64","author":"De Bock","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0560","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/0271678X16647396","article-title":"Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease","volume":"36","author":"De Guio","year":"2016","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0565","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","article-title":"Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein","volume":"391","author":"De Strooper","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0570","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.biopsych.2014.08.027","article-title":"Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium","volume":"77","author":"Debette","year":"2015","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0575","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.0000000000003482","article-title":"Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies","volume":"88","author":"Deckers","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0580","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0590","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3389\/fphys.2019.01269","article-title":"A novel model of mixed vascular dementia incorporating hypertension in a rat model of Alzheimer\u2019s disease","volume":"10","author":"Denver","year":"2019","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0595","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1460-9568.2009.07031.x","article-title":"Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice","volume":"31","author":"Devi","year":"2010","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0600","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-142976","article-title":"Is vasomotion in cerebral arteries impaired in Alzheimer\u2019s disease?","volume":"46","author":"Di Marco","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-122140","article-title":"A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer\u2019s disease","volume":"35","author":"Di Santo","year":"2013","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0610","first-page":"643","article-title":"Etude histochimique des plaques seniles","volume":"27","author":"Divry","year":"1927","journal-title":"Journal Belge de Neurologie et de Psychiatrie"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0615","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.02.010","article-title":"Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer\u2019s disease","volume":"81","author":"Do","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0620","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(99)00847-2","article-title":"Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein","volume":"277","author":"Dodart","year":"1999","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103458","article-title":"Granulocyte-colony stimulating factor attenuates oligomeric amyloid beta neurotoxicity by activation of neprilysin","volume":"9","author":"Doi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0630","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/01.jnen.0000171644.00180.fc","article-title":"Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease","volume":"64","author":"Domnitz","year":"2005","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0635","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1073\/pnas.96.11.6468","article-title":"Agrin in Alzheimer\u2019s disease: Altered solubility and abnormal distribution within microvasculature and brain parenchyma","volume":"96","author":"Donahue","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0640","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0645","doi-asserted-by":"crossref","first-page":"M173","DOI":"10.1093\/gerona\/57.3.M173","article-title":"Prevalence and impact of medical comorbidity in Alzheimer\u2019s disease","volume":"57","author":"Doraiswamy","year":"2002","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0650","doi-asserted-by":"crossref","first-page":"32691","DOI":"10.1073\/pnas.1908658117","article-title":"Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer\u2019s disease","volume":"117","author":"Dubey","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0655","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-143186","article-title":"Matrix metalloproteinases in Alzheimer\u2019s disease and concurrent cerebral microbleeds","volume":"48","author":"Duits","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0660","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/nan.12375","article-title":"Ageing causes prominent neurovascular dysfunction associated with loss of astrocytic contacts and gliosis","volume":"43","author":"Duncombe","year":"2017","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0665","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41419-020-2288-4","article-title":"Beta secretase 1-dependent amyloid precursor protein processing promotes excessive vascular sprouting through NOTCH3 signalling","volume":"11","author":"Durrant","year":"2020","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0670","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-amyloid-beta monoclonal antibodies for Alzheimer\u2019s disease: pitfalls and promise","volume":"83","author":"van Dyck","year":"2018","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0675","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0006-3223(90)90410-4","article-title":"Rapid dynamic CT scanning in primary degenerative dementia and age-matched controls","volume":"28","author":"Dysken","year":"1990","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0680","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/16.11.673","article-title":"X-ray diffraction studies on amyloid filaments","volume":"16","author":"Eanes","year":"1968","journal-title":"The Journal of Histochemistry and Cytochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0685","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JAD-180688","article-title":"Neuropathologic correlates of psychiatric symptoms in Alzheimer\u2019s disease","volume":"66","author":"Ehrenberg","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0690","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00685397","article-title":"Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study","volume":"57","author":"Eikelenboom","year":"1982","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0695","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2019.01.020","article-title":"Multi-faceted therapeutic strategy for treatment of Alzheimer\u2019s disease by concurrent administration of etodolac and alpha-tocopherol","volume":"125","author":"Elfakhri","year":"2019","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0700","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12818","article-title":"High-fat diet protects the blood-brain barrier in an Alzheimer's disease mouse model","volume":"17","author":"Elhaik Goldman","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0705","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0022-510X(85)90189-3","article-title":"CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis","volume":"70","author":"Elovaara","year":"1985","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0710","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-510X(83)90208-3","article-title":"Immunocytochemical studies of Alzheimer neuronal perikarya with intermediate filament antisera","volume":"62","author":"Elovaara","year":"1983","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0715","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1600-0404.1988.tb05925.x","article-title":"Oligoclonal immunoglobulin bands in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia","volume":"77","author":"Elovaara","year":"1988","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0720","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.2111583","article-title":"Cleavage of amyloid beta peptide during constitutive processing of its precursor","volume":"248","author":"Esch","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0725","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-4-22","article-title":"Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition","volume":"4","author":"Fan","year":"2007","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100942","article-title":"Shaping the Nrf2-ARE-related pathways in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"54","author":"Fao","year":"2019","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0735","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/jcbfm.2015.79","article-title":"Hypertension enhances Abeta-induced neurovascular dysfunction, promotes beta-secretase activity, and leads to amyloidogenic processing of APP","volume":"36","author":"Faraco","year":"2016","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0740","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jalz.2011.09.224","article-title":"Safety and biomarker effects of solanezumab in patients with Alzheimer\u2019s disease","volume":"8","author":"Farlow","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0745","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","article-title":"Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis","volume":"30","author":"Farrall","year":"2009","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0750","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trci.2016.06.002","article-title":"First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease","volume":"2","author":"Ferrero","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0755","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1365-2362.2002.00994.x","article-title":"Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer\u2019s disease brain and damage the blood-brain barrier","volume":"32","author":"Fiala","year":"2002","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0760","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/geronj\/42.2.180","article-title":"Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer\u2019s type","volume":"42","author":"Fillit","year":"1987","journal-title":"Journal of Gerontology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0765","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000211873","article-title":"Miliaere Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmassige Veraenderung der Hirnrinde bei seniler Demenz","volume":"22","author":"Fischer","year":"1907","journal-title":"Monatsschrift f\u00fcr Psychiatrie und Neurologie"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0770","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02893605","article-title":"Die presbyophrene Demenz, deren anatomische Grundlage und klinische Abgrenzung","volume":"3","author":"Fischer","year":"1910","journal-title":"Z Ges Neurololgy and Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0775","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1161\/STROKEAHA.110.593657","article-title":"Cerebral microbleeds in the elderly: a pathological analysis","volume":"41","author":"Fisher","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0780","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1161\/STROKEAHA.111.626655","article-title":"Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy","volume":"42","author":"Fisher","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0785","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3233\/JAD-132789","article-title":"Improvement of memory deficits and amyloid-beta clearance in aged APP23 mice treated with a combination of anti-amyloid-beta antibody and LXR agonist","volume":"41","author":"Fitz","year":"2014","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0790","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","article-title":"Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells","volume":"29","author":"Fleegal-DeMotta","year":"2009","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0795","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194735","article-title":"Predicting dementia from primary care records: A systematic review and meta-analysis","volume":"13","author":"Ford","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0800","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/archneur.1992.00530340054018","article-title":"Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study","volume":"49","author":"Forstl","year":"1992","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0805","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/ATVBAHA.118.311906","article-title":"Brain vasculature and cognition","volume":"39","author":"Fouda","year":"2019","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0810","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neurobiolaging.2019.09.017","article-title":"White matter hyperintensities mediate the association between blood-brain barrier leakage and information processing speed","volume":"85","author":"Freeze","year":"2020","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0815","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02279767","article-title":"Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF\/serum ratios of albumin and IgG","volume":"240","author":"Frolich","year":"1991","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0820","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","article-title":"Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model","volume":"25","author":"Fryer","year":"2005","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0825","first-page":"1633","article-title":"Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease","volume":"152","author":"Funato","year":"1998","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0830","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1007\/s12035-018-1002-3","article-title":"Chronic hippocampal expression of notch intracellular domain induces vascular thickening, reduces glucose availability, and exacerbates spatial memory deficits in a rat model of Early Alzheimer","volume":"55","author":"Galeano","year":"2018","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0835","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0840","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/j.1471-4159.2009.06096.x","article-title":"Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice","volume":"109","author":"Garcia-Alloza","year":"2009","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0845","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2012.06.052","article-title":"Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD","volume":"64","author":"Garcia-Barroso","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0850","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1160\/TH14-04-0298","article-title":"The role of actin-binding proteins in the control of endothelial barrier integrity","volume":"113","author":"Garcia-Ponce","year":"2015","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0855","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0022-510X(91)90218-V","article-title":"Age-related changes in cerebrospinal fluid protein concentrations","volume":"104","author":"Garton","year":"1991","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0860","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fmed.2018.00195","article-title":"Impact of bradykinin generation during thrombolysis in ischemic stroke","volume":"5","author":"Gauberti","year":"2018","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0865","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2016.01.001","article-title":"Cerebrovascular pathology during the progression of experimental Alzheimer\u2019s disease","volume":"88","author":"Giannoni","year":"2016","journal-title":"Neurobiology of Disease"},{"issue":"100","key":"10.1016\/j.pharmthera.2022.108119_bb0870","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1152\/japplphysiol.00966.2005","article-title":"Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease","volume":"1985","author":"Girouard","year":"2006","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0875","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0306-9877(79)90005-7","article-title":"Congophilic microangiopathy in the pathogenesis of Alzheimer\u2019s syndrome (presenile dementia)","volume":"5","author":"Glenner","year":"1979","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0880","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0885","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0890","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0197-4580(89)90076-6","article-title":"Amyloid plaques, neurofibrillary tangles and their relevance for the study of Alzheimer\u2019s disease","volume":"10","author":"Goedert","year":"1989","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0895","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3389\/fnins.2019.00541","article-title":"Fibrinogen chains intrinsic to the brain","volume":"13","author":"Golanov","year":"2019","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6107(02)00037-8","article-title":"Tight junction proteins","volume":"81","author":"Gonzalez-Mariscal","year":"2003","journal-title":"Progress in Biophysics and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0905","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1161\/STROKEAHA.109.558197","article-title":"Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition","volume":"40","author":"Goos","year":"2009","journal-title":"Stroke"},{"issue":"1011","key":"10.1016\/j.pharmthera.2022.108119_bb0910","first-page":"e1011","article-title":"Microbleeds relate to altered amyloid-beta metabolism in Alzheimer\u2019s disease","volume":"33","author":"Goos","year":"2012","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0915","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00005072-198409000-00003","article-title":"An immunologic assessment of brain-associated IgG in senile cerebral amyloidosis","volume":"43","author":"Goust","year":"1984","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0920","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1161\/STROKEAHA.117.018336","article-title":"Neuroimaging correlates of cerebral microbleeds: the ARIC study (atherosclerosis risk in communities)","volume":"48","author":"Graff-Radford","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0925","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)61105-4","article-title":"Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain","volume":"160","author":"Grammas","year":"2002","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0930","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","article-title":"Cerebral microbleeds: a guide to detection and interpretation","volume":"8","author":"Greenberg","year":"2009","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0935","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2990.2010.01140.x","article-title":"Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain","volume":"37","author":"Greenwood","year":"2011","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0940","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/NEN.0b013e3182729845","article-title":"Reducing available soluble beta-amyloid prevents progression of cerebral amyloid angiopathy in transgenic mice","volume":"71","author":"Gregory","year":"2012","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0945","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tips.2017.05.008","article-title":"The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs","volume":"38","author":"Grosser","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0950","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0955","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0960","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.410060612","article-title":"Alzheimer neurofibrillary tangles: Antiserum and immunohistological staining","volume":"6","author":"Grundke-Iqbal","year":"1979","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0965","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1182\/blood-2005-07-2994","article-title":"Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor","volume":"107","author":"Gu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0970","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3233\/JAD-190494","article-title":"Stroke and amyloid-beta downregulate TREM-2 and Uch-L1 expression that synergistically promote the inflammatory response","volume":"71","author":"Guglielmotto","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0975","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.parkreldis.2015.07.008","article-title":"Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer\u2019s disease","volume":"21","author":"Gungor","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0980","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.bbrc.2020.03.186","article-title":"Bilobalide reversibly modulates blood-brain barrier permeability through promoting adenosine A1 receptor-mediated phosphorylation of actin-binding proteins","volume":"526","author":"Guo","year":"2020","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0985","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/08923973.2014.913616","article-title":"Rapamycin alleviates brain edema after focal cerebral ischemia reperfusion in rats","volume":"36","author":"Guo","year":"2014","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0990","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-016-1551-3","article-title":"Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling","volume":"131","author":"Gurnik","year":"2016","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb0995","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1148\/radiol.2016152244","article-title":"Blood-brain barrier leakage in patients with early Alzheimer disease","volume":"281","author":"van de Haar","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1000","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1002\/mp.12328","article-title":"Subtle blood-brain barrier leakage rate and spatial extent: Considerations for dynamic contrast-enhanced MRI","volume":"44","author":"van de Haar","year":"2017","journal-title":"Medical Physics"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1005","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2016.06.006","article-title":"Neurovascular unit impairment in early Alzheimer\u2019s disease measured with magnetic resonance imaging","volume":"45","author":"van de Haar","year":"2016","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-015-1417-0","article-title":"Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin alpha-4-transduced outside-in signalling","volume":"129","author":"Haarmann","year":"2015","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease","volume":"36","author":"Halliday","year":"2016","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0079-6123(03)45012-7","article-title":"Cholinergic modulation of the cortical microvascular bed","volume":"145","author":"Hamel","year":"2004","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00002093-199903000-00002","article-title":"Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis","volume":"13","author":"Hampel","year":"1999","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1030","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s00415-003-0245-7","article-title":"Cerebral microbleeds in Alzheimer's disease","volume":"250","author":"Hanyu","year":"2003","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1035","doi-asserted-by":"crossref","first-page":"9526","DOI":"10.1523\/JNEUROSCI.3686-14.2015","article-title":"Hemichannels are required for amyloid beta-peptide-induced degranulation and are activated in brain mast cells of APPswe\/PS1dE9 mice","volume":"35","author":"Harcha","year":"2015","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5811\/westjem.2014.12.22933","article-title":"Anticoagulation drug therapy: A review","volume":"16","author":"Harter","year":"2015","journal-title":"The Western Journal of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1045","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1523\/JNEUROSCI.0664-05.2005","article-title":"Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer\u2019s disease","volume":"25","author":"Hartman","year":"2005","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/138920111795164020","article-title":"ABC transporters in the CNS - an inventory","volume":"12","author":"Hartz","year":"2011","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/STROKEAHA.111.627562","article-title":"Amyloid-beta contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy","volume":"43","author":"Hartz","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb5000","doi-asserted-by":"crossref","first-page":"893163","DOI":"10.1155\/2015\/893163","article-title":"Alleviation of kainic acid-induced brain barrier dysfunction by 4-o-methylhonokiol in in vitro and in vivo models","volume":"2015","author":"Han","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3233\/JAD-160013","article-title":"Influence of low-dose aspirin on cerebral amyloid angiopathy in mice","volume":"52","author":"Hattori","year":"2016","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-011-0801-7","article-title":"Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy","volume":"121","author":"Hawkes","year":"2011","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1070","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1075","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1212\/WNL.0b013e31823b4765","article-title":"Chronic kidney disease, cognitive decline, and incident dementia: the 3C study","volume":"77","author":"Helmer","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphys.2019.00065","article-title":"Measurement of neurovascular coupling in neonates","volume":"10","author":"Hendrikx","year":"2019","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1750-3639.2008.00257.x","article-title":"Reduction of cerebral oxidative stress following environmental enrichment in mice with Alzheimer-like pathology","volume":"20","author":"Herring","year":"2010","journal-title":"Brain Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1090","doi-asserted-by":"crossref","first-page":"C1583","DOI":"10.1152\/ajpcell.00458.2009","article-title":"TRPC-mediated actin-myosin contraction is critical for BBB disruption following hypoxic stress","volume":"298","author":"Hicks","year":"2010","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1095","first-page":"283","article-title":"Ultrastructural changes of blood vessels in the cerebral cortex in Alzheimer's disease","volume":"41","author":"Higuchi","year":"1987","journal-title":"The Japanese Journal of Psychiatry and Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0008-6363(96)00063-6","article-title":"Pericytes in the microvasculature","volume":"32","author":"Hirschi","year":"1996","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1105","series-title":"Goodman & Gilman\u2019s: The pharmacological basis of therapeutics, 13e","article-title":"Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs","author":"Hogg","year":"2017"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1194\/jlr.M057869","article-title":"Global changes of phospholipids identified by MALDI imaging mass spectrometry in a mouse model of Alzheimer\u2019s disease","volume":"57","author":"Hong","year":"2016","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s004010100414","article-title":"Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer\u2019s disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains","volume":"102","author":"van Horssen","year":"2001","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1120","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3389\/fneur.2019.00878","article-title":"Precuneus-dominant degeneration of parietal lobe is at risk of epilepsy in mild Alzheimer's disease","volume":"10","author":"Horvath","year":"2019","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4236\/nm.2013.42013","article-title":"Absence of nitric oxide synthase 3 increases amyloid beta-protein pathology in Tg-5xFAD mice","volume":"4","author":"Hu","year":"2013","journal-title":"Medical Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1135","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1096\/fj.201800200R","article-title":"Cerebrovascular beta-amyloid deposition and associated microhemorrhages in a Tg2576 Alzheimer mouse model are reduced with a DHA-enriched diet","volume":"32","author":"Hur","year":"2018","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.freeradbiomed.2013.08.005","article-title":"Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation","volume":"65","author":"Hyeon","year":"2013","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/scientificamerican0686-42","article-title":"Fibronectins","volume":"254","author":"Hynes","year":"1986","journal-title":"Scientific American"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer's disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1155","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1165","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archneurol.2011.830","article-title":"Incidence of new-onset seizures in mild to moderate Alzheimer disease","volume":"69","author":"Irizarry","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1170","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","article-title":"APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1","volume":"56","author":"Irizarry","year":"1997","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00689569","article-title":"Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique","volume":"32","author":"Ishii","year":"1975","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00685368","article-title":"Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques","volume":"36","author":"Ishii","year":"1976","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-5728(89)90115-X","article-title":"Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease","volume":"24","author":"Itagaki","year":"1989","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1190","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain beta-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1195","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1111\/ejn.13442","article-title":"Human tau increases amyloid beta plaque size but not amyloid beta-mediated synapse loss in a novel mouse model of Alzheimer\u2019s disease","volume":"44","author":"Jackson","year":"2016","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2016.11.017","article-title":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","volume":"51","author":"Janelidze","year":"2017","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12974-016-0722-4","article-title":"Interferon-gamma blocks signalling through PDGFRbeta in human brain pericytes","volume":"13","author":"Jansson","year":"2016","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1215","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cellsig.2014.05.019","article-title":"Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer\u2019s disease","volume":"26","author":"Jarre","year":"2014","journal-title":"Cellular Signalling"},{"issue":"196","key":"10.1016\/j.pharmthera.2022.108119_bb1220","first-page":"e129","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.58.4.671","article-title":"Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study","volume":"58","author":"Jellinger","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1230","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0197-4580(97)00048-1","article-title":"Neuropathological staging of Alzheimer-related lesions: the challenge of establishing relations to age","volume":"18","author":"Jellinger","year":"1997","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1235","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1471-4159.1988.tb01135.x","article-title":"Glycosaminoglycans in cortical autopsy samples from Alzheimer brain","volume":"51","author":"Jenkins","year":"1988","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1240","doi-asserted-by":"crossref","first-page":"390","DOI":"10.14336\/AD.2019.0519","article-title":"Alteration in the function and expression of SLC and ABC transporters in the neurovascular unit in Alzheimer's disease and the clinical significance","volume":"11","author":"Jia","year":"2020","journal-title":"Aging and Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010549","article-title":"Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer\u2019s disease","volume":"5","author":"Jordao","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.expneurol.2013.05.008","article-title":"Amyloid-beta plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound","volume":"248","author":"Jordao","year":"2013","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS."},{"key":"10.1016\/j.pharmthera.2022.108119_bb1260","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1997.tb48478.x","article-title":"Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer\u2019s disease","volume":"826","author":"Kalaria","year":"1997","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1265","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.410320417","article-title":"Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer\u2019s disease","volume":"32","author":"Kalaria","year":"1992","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-8993(95)01250-8","article-title":"Increased collagen content of cerebral microvessels in Alzheimer\u2019s disease","volume":"705","author":"Kalaria","year":"1995","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1275","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fnagi.2020.00151","article-title":"Excessive production of transforming growth factor beta1 causes mural cell depletion from cerebral small vessels","volume":"12","author":"Kato","year":"2020","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1280","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1285","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0197-4580(87)90053-4","article-title":"CSF and serum concentrations of albumin and IgG in Alzheimer\u2019s disease","volume":"8","author":"Kay","year":"1987","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1290","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbadis.2015.08.024","article-title":"Deposition of amyloid beta in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy","volume":"1862","author":"Keable","year":"2016","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1295","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500472","article-title":"Autoregulated paracellular clearance of amyloid-beta across the blood-brain barrier","volume":"1","author":"Keaney","year":"2015","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1300","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0197-4580(02)00098-2","article-title":"Progressive age-related impairment of cognitive behavior in APP23 transgenic mice","volume":"24","author":"Kelly","year":"2003","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1310","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2014.754","article-title":"Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers","volume":"71","author":"Kester","year":"2014","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1315","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1096\/fj.05-4829fje","article-title":"The phosphatidylinositol-3 kinase\/Akt pathway mediates VEGF\u2019s neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia","volume":"20","author":"Kilic","year":"2006","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1320","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1325","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1212\/01.wnl.0000345666.83318.03","article-title":"Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy","volume":"72","author":"Kimberly","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1330","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1093\/brain\/awv327","article-title":"Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer\u2019s disease","volume":"138","author":"Kimbrough","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1335","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1292\/jvms.67.961","article-title":"Changes of magnetic resonance imaging on the brain in beagle dogs with aging","volume":"67","author":"Kimotsuki","year":"2005","journal-title":"The Journal of Veterinary Medical Science"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1340","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bpa.12895","article-title":"Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer\u2019s disease","volume":"30","author":"Kirabali","year":"2020","journal-title":"Brain Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1345","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnen\/nlv018","article-title":"Altered levels of visinin-like protein 1 correspond to regional neuronal loss in Alzheimer disease and frontotemporal lobar degeneration","volume":"75","author":"Kirkwood","year":"2016","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1350","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195469","article-title":"Memory deficiency, cerebral amyloid angiopathy, and amyloid-beta plaques in APP+PS1 double transgenic rat model of Alzheimer\u2019s disease","volume":"13","author":"Klakotskaia","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1360","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1523\/JNEUROSCI.6102-11.2012","article-title":"Abeta(1)(-)(4)(2)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca(2)(+)-calcineurin signaling","volume":"32","author":"Kook","year":"2012","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1365","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.26","article-title":"High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice","volume":"5","author":"Kook","year":"2014","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1370","doi-asserted-by":"crossref","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","article-title":"Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease","volume":"268","author":"Kopke","year":"1993","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1375","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1460-9568.2008.06329.x","article-title":"Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load","volume":"28","author":"Koson","year":"2008","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1380","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4049\/jimmunol.176.2.1218","article-title":"Ezrin\/radixin\/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells","volume":"176","author":"Koss","year":"2006","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1385","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1016\/S0021-9258(18)83797-8","article-title":"Identification of integrin collagen receptors on human melanoma cells","volume":"264","author":"Kramer","year":"1989","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1390","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1471-4159.2007.04506.x","article-title":"Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption","volume":"102","author":"Kuhlmann","year":"2007","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1395","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)62995-1","article-title":"Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls","volume":"167","author":"Kumar-Singh","year":"2005","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1400","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF03401867","article-title":"The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease","volume":"7","author":"Kuo","year":"2001","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1405","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.626636","article-title":"A systematic review of glucose transport alterations in Alzheimer\u2019s disease","volume":"15","author":"Kyrtata","year":"2021","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1410","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.neuron.2014.07.034","article-title":"Sensory-related neural activity regulates the structure of vascular networks in the cerebral cortex","volume":"83","author":"Lacoste","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1415","doi-asserted-by":"crossref","first-page":"e2259","DOI":"10.1212\/WNL.0000000000010612","article-title":"Association of epileptiform abnormalities and seizures in Alzheimer disease","volume":"95","author":"Lam","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1420","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/WNF.0b013e31827db49b","article-title":"Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study","volume":"36","author":"Landen","year":"2013","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1425","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/cne.23355","article-title":"Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain","volume":"521","author":"Langlet","year":"2013","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1430","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2990.2006.00747.x","article-title":"Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study","volume":"32","author":"Lashley","year":"2006","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1435","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40478-019-0743-1","article-title":"Resistance and resilience to Alzheimer\u2019s disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort","volume":"7","author":"Latimer","year":"2019","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1440","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1084\/jem.20181035","article-title":"3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice","volume":"216","author":"Lazic","year":"2019","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1445","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2377-7-14","article-title":"Fibrinogen gamma-A chain precursor in CSF: A candidate biomarker for Alzheimer\u2019s disease","volume":"7","author":"Lee","year":"2007","journal-title":"BMC Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1450","article-title":"White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer\u2019s disease","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1455","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jgs.16181","article-title":"Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease","volume":"68","author":"Lee","year":"2020","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1460","doi-asserted-by":"crossref","first-page":"36945","DOI":"10.1074\/jbc.M110.127738","article-title":"Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP\/PS1DeltaE9 mice","volume":"285","author":"Lefterov","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1465","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnins.2018.00055","article-title":"Safety and efficacy of scanning ultrasound treatment of aged APP23 mice","volume":"12","author":"Leinenga","year":"2018","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1470","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainresbull.2019.08.002","article-title":"Scanning ultrasound in the absence of blood-brain barrier opening is not sufficient to clear beta-amyloid plaques in the APP23 mouse model of Alzheimer\u2019s disease","volume":"153","author":"Leinenga","year":"2019","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1475","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0022-510X(85)90121-2","article-title":"The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid","volume":"67","author":"Leonardi","year":"1985","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1480","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1023\/A:1020747716815","article-title":"Prothrombin in normal human cerebrospinal fluid originates from the blood","volume":"23","author":"Lewczuk","year":"1998","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1485","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1023\/A:1021147914843","article-title":"Prothrombin concentration in the cerebrospinal fluid is not altered in Alzheimer's disease","volume":"24","author":"Lewczuk","year":"1999","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1490","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainresbull.2018.06.010","article-title":"Adenoviral vector-induced silencing of RGMa attenuates blood-brain barrier dysfunction in a rat model of MCAO\/reperfusion","volume":"142","author":"Li","year":"2018","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1495","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0646-14.2014","article-title":"Anti-ApoE antibody given after plaque onset decreases Abeta accumulation and improves brain function in a mouse model of Abeta amyloidosis","volume":"34","author":"Liao","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1500","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1387\/ijdb.103224sl","article-title":"Current concepts of blood-brain barrier development","volume":"55","author":"Liebner","year":"2011","journal-title":"The International Journal of Developmental Biology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1505","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13668-017-0187-9","article-title":"Neuroimaging Biomarkers of Caloric Restriction on Brain Metabolic and Vascular Functions","volume":"6","author":"Lin","year":"2017","journal-title":"Current Nutrition Reports"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104834","article-title":"APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer\u2019s disease","volume":"139","author":"Lin","year":"2020","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1515","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","article-title":"Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer\u2019s disease","volume":"33","author":"Lin","year":"2013","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1520","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","article-title":"Pericyte loss and microaneurysm formation in PDGF-B-deficient mice","volume":"277","author":"Lindahl","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1525","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.wad.0000213844.21001.a2","article-title":"New insight into Alzheimer disease: Demonstration of fibrin(ogen)-serum albumin insoluble deposits in brain tissue","volume":"20","author":"Lipinski","year":"2006","journal-title":"Alzheimer Disease and Associated Disorders"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108119_bb6000","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-200063","article-title":"SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer's Disease","volume":"75","author":"Liu","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1535","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00687397","article-title":"Immunohistochemical localization of intracellular plasma proteins in the human central nervous system","volume":"78","author":"Liu","year":"1989","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1540","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2017.10.015","article-title":"Investigating the efficacy of a combination Abeta-targeted treatment in a mouse model of Alzheimer\u2019s disease","volume":"1678","author":"Liu","year":"2018","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1545","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.029","article-title":"Clinical and pathological benefit of Twendee X in Alzheimer's disease transgenic mice with chronic cerebral hypoperfusion","volume":"28","author":"Liu","year":"2019","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1550","article-title":"Twendee X ameliorates phosphorylated Tau, alpha-synuclein and neurovascular dysfunction in Alzheimer's disease transgenic mice with chronic cerebral hypoperfusion","volume":"28","author":"Liu","year":"2019","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1555","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-020-0891-3","article-title":"Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer\u2019s disease","volume":"8","author":"Lloyd","year":"2020","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1560","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/eye.2009.162","article-title":"The effects of hypoxia on the ERG in paediatric cerebral malaria","volume":"24","author":"Lochhead","year":"2010","journal-title":"Eye (London, England)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1565","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-016-0181-2","article-title":"Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective A\u03b2 antibody","volume":"8","author":"Logovinsky","year":"2016","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1570","doi-asserted-by":"crossref","first-page":"11344","DOI":"10.1038\/s41598-018-29341-6","article-title":"Blast exposure elicits blood-brain barrier disruption and repair mediated by tight junction integrity and nitric oxide dependent processes","volume":"8","author":"Logsdon","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1575","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jnen\/nlaa016","article-title":"Heparan sulfate proteoglycans undergo differential expression alterations in Alzheimer disease brains","volume":"79","author":"Lorente-Gea","year":"2020","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1580","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","article-title":"Cerebrovascular disease in ageing and Alzheimer\u2019s disease","volume":"131","author":"Love","year":"2016","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1585","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0006-8993(01)02758-5","article-title":"Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer\u2019s disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology","volume":"913","author":"Luth","year":"2001","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1590","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7150\/ijms.36775","article-title":"Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer\u2019s disease","volume":"18","author":"Lynch","year":"2021","journal-title":"International Journal of Medical Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177447","article-title":"Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat model","volume":"12","author":"Machida","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1600","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/bi061359o","article-title":"Granular tau oligomers as intermediates of tau filaments","volume":"46","author":"Maeda","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1605","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neurobiolaging.2018.06.004","article-title":"The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier","volume":"70","author":"Magaki","year":"2018","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217216","article-title":"Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies","volume":"14","author":"Majerova","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1615","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jacl.2014.02.012","article-title":"An assessment by the Statin Diabetes Safety Task Force: 2014 update","volume":"8","author":"Maki","year":"2014","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1620","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00692225","article-title":"Thickening of the basement membrane of cortical capillaries in Alzheimer\u2019s disease","volume":"49","author":"Mancardi","year":"1980","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1625","first-page":"516","article-title":"Assessment of immunoglobulin use for hepatitis A control in New Mexico","volume":"97","author":"Mann","year":"1982","journal-title":"Public Health Reports"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1630","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2016-03-705384","article-title":"Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin- and bradykinin-dependent mechanism","volume":"128","author":"Marcos-Contreras","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1635","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0038-1650246","article-title":"Hemostasis abnormalities in patients with vascular dementia and Alzheimer\u2019s disease","volume":"75","author":"Mari","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1640","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/STROKEAHA.117.017994","article-title":"Cerebral microbleeds in murine amyloid angiopathy: natural course and anticoagulant effects","volume":"48","author":"Marinescu","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1645","doi-asserted-by":"crossref","DOI":"10.1177\/1759091417719201","article-title":"Peripheral inflammation, apolipoprotein E4, and amyloid-beta interact to induce cognitive and cerebrovascular dysfunction","volume":"9","author":"Marottoli","year":"2017","journal-title":"ASN Neuro"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1650","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1242\/dev.124.19.3909","article-title":"Integrins mediate adhesion to agrin and modulate agrin signaling","volume":"124","author":"Martin","year":"1997","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1655","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnen\/60.4.357","article-title":"Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein","volume":"60","author":"Masliah","year":"2001","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1660","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/00313028409068528","article-title":"Etiology and pathogenesis of Alzheimer\u2019s disease","volume":"16","author":"Masters","year":"1984","journal-title":"Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1665","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1670","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000100019","article-title":"Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease","volume":"23","author":"Matsumoto","year":"2007","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1675","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000112555","article-title":"Cerebrospinal fluid\/serum IgG index is correlated with medial temporal lobe atrophy in Alzheimer's disease","volume":"25","author":"Matsumoto","year":"2008","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1680","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1690","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1157.1992.tb02343.x","article-title":"Epileptic seizures in elderly patients with dementia","volume":"33","author":"McAreavey","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1695","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/jbc.R116.760215","article-title":"The Translational Significance of the Neurovascular Unit","volume":"292","author":"McConnell","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1700","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/jnnp-2016-315022","article-title":"7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature","volume":"88","author":"McKiernan","year":"2017","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1705","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/HYPERTENSIONAHA.115.06146","article-title":"Nrf2 as an endothelial mechanosensitive transcription factor: Going with the flow","volume":"67","author":"McSweeney","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1710","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0404.1991.tb04940.x","article-title":"Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias","volume":"84","author":"Mecocci","year":"1991","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1715","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/sj.emboj.7600650","article-title":"Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1\/2 activation","volume":"24","author":"Medina","year":"2005","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1720","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00002512-200320110-00001","article-title":"Seizures in elderly patients with dementia: epidemiology and management","volume":"20","author":"Mendez","year":"2003","journal-title":"Drugs & Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1725","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/089198879400700407","article-title":"Seizures in Alzheimer\u2019s disease: clinicopathologic study","volume":"7","author":"Mendez","year":"1994","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1730","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-016-1560-2","article-title":"Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer\u2019s disease-related microvascular cerebral amyloid angiopathy","volume":"131","author":"Merlini","year":"2016","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1735","doi-asserted-by":"crossref","first-page":"e1580","DOI":"10.1212\/WNL.0000000000007247","article-title":"Cortical cholinergic denervation in primary progressive aphasia with Alzheimer pathology","volume":"92","author":"Mesulam","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1740","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1073\/pnas.0709788105","article-title":"Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer\u2019s disease","volume":"105","author":"Meyer","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1745","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ar.22878","article-title":"VEGF increases paracellular permeability in brain endothelial cells via upregulation of EphA2","volume":"297","author":"Miao","year":"2014","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1750","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3389\/fneur.2019.00966","article-title":"Effects of dabigatran in mouse models of aging and cerebral amyloid angiopathy","volume":"10","author":"Michael","year":"2019","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1755","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030571","article-title":"Dual roles of astrocyte-derived factors in regulation of blood-brain barrier function after brain damage","volume":"20","author":"Michinaga","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1760","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0278-5846(95)00031-P","article-title":"Endothelin-1-like immunoreactivity in cerebral cortex of Alzheimer-type dementia","volume":"19","author":"Minami","year":"1995","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1765","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13195-019-0534-8","article-title":"CSF evidence of pericyte damage in Alzheimer\u2019s disease is associated with markers of blood-brain barrier dysfunction and disease pathology","volume":"11","author":"Miners","year":"2019","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1770","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0271678X17690761","article-title":"Differing associations between A\u03b2 accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer\u2019s disease","volume":"38","author":"Miners","year":"2018","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1775","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.neurobiolaging.2013.12.026","article-title":"Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP\/PS1 mice","volume":"35","author":"Minogue","year":"2014","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1780","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1042\/CS20160927","article-title":"Kidney-brain axis inflammatory cross-talk: from bench to bedside","volume":"131","author":"Miranda","year":"2017","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1785","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0000000000000251","article-title":"Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease","volume":"82","author":"Miwa","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1790","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","article-title":"Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain","volume":"274","author":"Moechars","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1795","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000054814","article-title":"Regional variations in the transport of interleukin-1alpha across the blood-brain barrier in ICR and aging SAMP8 mice","volume":"8","author":"Moiuddin","year":"2000","journal-title":"Neuroimmunomodulaton"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1800","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/925702","article-title":"Efficacy of memantine, donepezil, or their association in moderate-severe Alzheimer\u2019s disease: A review of clinical trials","volume":"2013","author":"Molino","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1805","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1810","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00401-016-1570-0","article-title":"Brain imaging of neurovascular dysfunction in Alzheimer\u2019s disease","volume":"131","author":"Montagne","year":"2016","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1815","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1820","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: A matter of blood-brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1825","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0197-4580(88)80013-7","article-title":"Effect of aging on the blood-brain barrier","volume":"9","author":"Mooradian","year":"1988","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1830","series-title":"Proceedings of the 1st international congress on neuropathology, Rome","first-page":"347","article-title":"General and cellular pathochemistry of senile and presenile alterations of the brain","author":"Morel","year":"1954"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1835","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1096\/fj.01-0776com","article-title":"Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration","volume":"16","author":"Mori","year":"2002","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1840","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcpa.2005.01.001","article-title":"Immunohistochemical and ultrastructural findings related to the blood--brain barrier in the blood vessels of the cerebral white matter in aged dogs","volume":"133","author":"Morita","year":"2005","journal-title":"Journal of Comparative Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1845","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1850","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1523\/JNEUROSCI.23-23-08231.2003","article-title":"Age-dependent impairment of somatosensory response in the amyloid precursor protein 23 transgenic mouse model of Alzheimer's disease","volume":"23","author":"Mueggler","year":"2003","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1855","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1523\/JNEUROSCI.22-16-07218.2002","article-title":"Compromised hemodynamic response in amyloid precursor protein transgenic mice","volume":"22","author":"Mueggler","year":"2002","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1860","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.1997.tb48469.x","article-title":"Serum protein leakage in Alzheimer\u2019s disease revisited","volume":"826","author":"Munoz","year":"1997","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1865","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apha.12250","article-title":"The neurovascular unit - concept review","volume":"210","author":"Muoio","year":"2014","journal-title":"Acta Physiologica (Oxford, England)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1870","doi-asserted-by":"crossref","first-page":"20967","DOI":"10.1074\/jbc.273.33.20967","article-title":"Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells","volume":"273","author":"Murphy","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1875","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3233\/JAD-200168","article-title":"Cerebrospinal fluid\/plasma albumin ratio as a biomarker for blood-brain barrier impairment across neurodegenerative dementias","volume":"75","author":"Musaeus","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1880","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3233\/JAD-170220","article-title":"The relationship between markers of inflammation and degeneration in the central nervous system and the blood-brain barrier impairment in Alzheimer's disease","volume":"59","author":"Muszynski","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1885","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.036","article-title":"Prevalence and clinicoradiological analyses of patients with Alzheimer disease coexisting multiple microbleeds","volume":"23","author":"Nagasawa","year":"2014","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1890","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3233\/JAD-141200","article-title":"Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia","volume":"42","author":"Nagga","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1895","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.exger.2016.11.012","article-title":"Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II","volume":"87","author":"Nakagawa","year":"2017","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1900","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ajh\/hpw099","article-title":"Transient mild cerebral ischemia significantly deteriorated cognitive impairment in a mouse model of Alzheimer's disease via angiotensin AT1 receptor","volume":"30","author":"Nakagawa","year":"2017","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1905","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0684.1998.tb00244.x","article-title":"Histopathological studies of senile plaques and cerebral amyloidosis in cynomolgus monkeys","volume":"27","author":"Nakamura","year":"1998","journal-title":"Journal of Medical Primatology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1910","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.2002.tb04813.x","article-title":"Subclinical brain hemorrhages in Alzheimer's disease: evaluation by magnetic resonance T2*-weighted images","volume":"977","author":"Nakata","year":"2002","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1915","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000092958","article-title":"Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease","volume":"22","author":"Nakata-Kudo","year":"2006","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1920","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1925","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2990.2011.01246.x","article-title":"Cerebral amyloid beta(42) deposits and microvascular pathology in ageing baboons","volume":"38","author":"Ndung\u2019u","year":"2012","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1930","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1935","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbd.2006.11.011","article-title":"Soluble adhesion molecules and angiotensin-converting enzyme in dementia","volume":"26","author":"Nielsen","year":"2007","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1940","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/156720512800107537","article-title":"Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia","volume":"9","author":"Nielsen","year":"2012","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1945","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study","volume":"64","author":"Nixon","year":"2005","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1950","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3233\/JAD-160651","article-title":"Cerebral amyloid angiopathy-related microbleeds and cerebrospinal fluid biomarkers in Alzheimer's disease","volume":"55","author":"Noguchi-Shinohara","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1955","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0196-9781(02)00248-6","article-title":"Regional differences in PACAP transport across the blood-brain barrier in mice: A possible influence of strain, amyloid beta protein, and age","volume":"23","author":"Nonaka","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1960","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s11357-020-00256-3","article-title":"Increases in hypertension-induced cerebral microhemorrhages exacerbate gait dysfunction in a mouse model of Alzheimer's disease","volume":"42","author":"Nyul-Toth","year":"2020","journal-title":"Geroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1965","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1970","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1975","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/bpa.12660","article-title":"Clusterin contributes to early stage of Alzheimer\u2019s disease pathogenesis","volume":"29","author":"Oh","year":"2019","journal-title":"Brain Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1980","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/01.STR.0000189721.31432.26","article-title":"Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia","volume":"36","author":"van Oijen","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1985","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.stemcr.2020.03.011","article-title":"Altered brain endothelial cell phenotype from a familial Alzheimer mutation and its potential implications for amyloid clearance and drug delivery","volume":"14","author":"Oikari","year":"2020","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1990","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1533317513517043","article-title":"Pattern of and risk factors for brain microbleeds in neurodegenerative dementia","volume":"29","author":"Olazaran","year":"2014","journal-title":"American Journal of Alzheimer's Disease and Other Dementias"},{"key":"10.1016\/j.pharmthera.2022.108119_bb1995","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2000","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2014.04.018","article-title":"Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer\u2019s disease model","volume":"68","author":"Ongali","year":"2014","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2005","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1038\/jcbfm.2011.99","article-title":"Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by beta(1)-integrins","volume":"31","author":"Osada","year":"2011","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2010","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3233\/JAD-2012-111760","article-title":"Endothelin-1 is elevated in Alzheimer\u2019s disease and upregulated by amyloid-beta","volume":"29","author":"Palmer","year":"2012","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2020","article-title":"Insulin therapy--role beyond glucose control","volume":"102","author":"Pandit","year":"2004","journal-title":"Journal of the Indian Medical Association"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jconrel.2020.09.015","article-title":"Role for caveolin-mediated transcytosis in facilitating transport of large cargoes into the brain via ultrasound","volume":"327","author":"Pandit","year":"2020","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2030","doi-asserted-by":"crossref","first-page":"29390","DOI":"10.1074\/jbc.272.46.29390","article-title":"Slow degradation of aggregates of the Alzheimer\u2019s disease amyloid beta-protein by microglial cells","volume":"272","author":"Paresce","year":"1997","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/acel.12530","article-title":"Annexin A1 restores Abeta1-42 -induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway","volume":"16","author":"Park","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2040","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.neurobiolaging.2014.03.008","article-title":"Intracellular amyloid beta alters the tight junction of retinal pigment epithelium in 5XFAD mice","volume":"35","author":"Park","year":"2014","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2045","article-title":"Omega-3 fatty acid-type docosahexaenoic acid protects against abeta-mediated mitochondrial deficits and pathomechanisms in Alzheimer\u2019s disease-related animal model","volume":"21","author":"Park","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0271678X15606720","article-title":"Experimental hypertension increases spontaneous intracerebral hemorrhages in a mouse model of cerebral amyloidosis","volume":"36","author":"Passos","year":"2016","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcp.21845","article-title":"Fibrinogen induces alterations of endothelial cell tight junction proteins","volume":"221","author":"Patibandla","year":"2009","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data","volume":"3","author":"Patlak","year":"1983","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2065","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20070304","article-title":"Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer\u2019s disease","volume":"204","author":"Paul","year":"2007","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/84675","article-title":"Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke","volume":"7","author":"Paul","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2075","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.mad.2007.07.002","article-title":"Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence","volume":"128","author":"Pelegri","year":"2007","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ajh.2010.241","article-title":"Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats","volume":"24","author":"Pelisch","year":"2011","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2085","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archneur.65.6.790","article-title":"Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study","volume":"65","author":"Pettersen","year":"2008","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2090","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuron.2011.08.009","article-title":"Role of astrocytes in neurovascular coupling","volume":"71","author":"Petzold","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2095","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3233\/JAD-2011-110896","article-title":"Seizures can precede cognitive symptoms in late-onset Alzheimer's disease","volume":"27","author":"Picco","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/nbdi.2001.0402","article-title":"Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer\u2019s disease","volume":"8","author":"Poduslo","year":"2001","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2105","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1432-1033.1994.tb19080.x","article-title":"Conformational changes of the recombinant extracellular domain of E-cadherin upon calcium binding","volume":"223","author":"Pokutta","year":"1994","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2110","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00415-016-8220-2","article-title":"Cerebral microbleeds in early Alzheimer's disease","volume":"263","author":"Poliakova","year":"2016","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2115","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.7150\/thno.52710","article-title":"Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments","volume":"11","author":"Poon","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00688609","article-title":"Permanganate oxidation of senile cerebral amyloid and its relationship to AA protein","volume":"58","author":"Powers","year":"1982","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156720208785425729","article-title":"Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase","volume":"5","author":"Provias","year":"2008","journal-title":"Current Neurovascular Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/156720511795256026","article-title":"Correlation analysis of capillary APOE, VEGF and eNOS expression in Alzheimer brains","volume":"8","author":"Provias","year":"2011","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2135","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/191863","article-title":"The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer's disease","volume":"2014","author":"Provias","year":"2014","journal-title":"International Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2140","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.2420006","article-title":"Platelet membrane glycoprotein IIb\/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors","volume":"231","author":"Pytela","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2145","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/acschemneuro.5b00190","article-title":"Oleocanthal enhances amyloid-beta clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model","volume":"6","author":"Qosa","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2150","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jnutbio.2015.07.022","article-title":"Extra-virgin olive oil attenuates amyloid-beta and tau pathologies in the brains of TgSwDI mice","volume":"26","author":"Qosa","year":"2015","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1971400917720465","article-title":"Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer\u2019s disease?","volume":"30","author":"Rabelo","year":"2017","journal-title":"The Neuroradiology Journal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2160","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","article-title":"Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta","volume":"25","author":"Racke","year":"2005","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3233\/JAD-160663","article-title":"Neuroprotective effect of TREM-2 in aging and Alzheimer\u2019s disease model","volume":"55","author":"Raha","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuropharm.2017.10.034","article-title":"MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies","volume":"134","author":"Raja","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2175","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1089\/neu.2011.1799","article-title":"Mild stretch-induced injury increases susceptibility to interleukin-1beta-induced release of matrix metalloproteinase-9 from astrocytes","volume":"28","author":"Ralay Ranaivo","year":"2011","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yebeh.2008.08.012","article-title":"Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome","volume":"14","author":"Rao","year":"2009","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-180797","article-title":"Increased hyaluronan and TSG-6 in association with neuropathologic changes of Alzheimer\u2019s disease","volume":"67","author":"Reed","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2190","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers","volume":"36","author":"Rempe","year":"2016","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2195","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1523\/JNEUROSCI.2751-17.2018","article-title":"Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy","volume":"38","author":"Rempe","year":"2018","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000332611","article-title":"Hippocampal microbleed on a post-mortem t(2) *-weighted gradient-echo 7.0-tesla magnetic resonance imaging?","volume":"3","author":"Reuck","year":"2011","journal-title":"Case Reports in Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010126","article-title":"Statin therapy and the development of cerebral amyloid angiopathy--a rodent in vivo approach","volume":"17","author":"Reuter","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fnagi.2016.00170","article-title":"Development of cerebral microbleeds in the APP23-transgenic mouse model of cerebral amyloid angiopathy-A 9.4 tesla MRI study","volume":"8","author":"Reuter","year":"2016","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2215","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3233\/JAD-2010-100849","article-title":"Morphometric changes in the cortical microvascular network in Alzheimer\u2019s disease","volume":"22","author":"Richard","year":"2010","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2220","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00702-012-0794-y","article-title":"Distribution of granulocyte-monocyte colony-stimulating factor and its receptor alpha-subunit in the adult human brain with specific reference to Alzheimer\u2019s disease","volume":"119","author":"Ridwan","year":"2012","journal-title":"Journal of Neural Transmission (Vienna)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2010-1224","article-title":"Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer\u2019s disease","volume":"19","author":"Rinne","year":"2010","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2230","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1523\/JNEUROSCI.3854-05.2006","article-title":"Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease","volume":"26","author":"Robbins","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12974-020-01956-5","article-title":"Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer\u2019s disease","volume":"17","author":"Robison","year":"2020","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2240","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12917-018-1700-0","article-title":"Multiple infarcts and hemorrhages in the central nervous system of a dog with cerebral amyloid angiopathy: A case report","volume":"14","author":"Rodrigues","year":"2018","journal-title":"BMC Veterinary Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2245","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ar.a.10069","article-title":"Morphological features in human cortical brain microvessels after head injury: a three-dimensional and immunocytochemical study","volume":"273","author":"Rodriguez-Baeza","year":"2003","journal-title":"The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2250","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3233\/JAD-150659","article-title":"JNK: A putative link between insulin signaling and VGLUT1 in Alzheimer\u2019s disease","volume":"50","author":"Rodriguez-Perdigon","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2255","doi-asserted-by":"crossref","first-page":"20631","DOI":"10.1074\/jbc.271.34.20631","article-title":"Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer\u2019s disease","volume":"271","author":"Roher","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2260","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2265","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4239\/wjd.v12.i6.745","article-title":"Alzheimer's disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links","volume":"12","author":"Rojas","year":"2021","journal-title":"World Journal of Diabetes"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2270","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archneur.1990.00530080029006","article-title":"Advanced Alzheimer\u2019s disease is a risk factor for late-onset seizures","volume":"47","author":"Romanelli","year":"1990","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2275","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1582-4934.2007.00047.x","article-title":"Occludin is overexpressed in Alzheimer\u2019s disease and vascular dementia","volume":"11","author":"Romanitan","year":"2007","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s007020170091","article-title":"Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer\u2019s disease patients","volume":"108","author":"R\u00f6sler","year":"2001","journal-title":"Journal of Neural Transmission (Vienna)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2285","first-page":"249","article-title":"Albumin synthesis","volume":"21","author":"Rothschild","year":"1980","journal-title":"International Review of Physiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2290","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104644","article-title":"Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease","volume":"134","author":"Royea","year":"2020","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2295","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and therapeutic potential of VEGF in the nervous system","volume":"89","author":"Ruiz de Almodovar","year":"2009","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2300","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/j.1582-4934.2008.00434.x","article-title":"A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer\u2019s disease brain","volume":"13","author":"Ryu","year":"2009","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40120-017-0069-5","article-title":"Increasing precision of clinical diagnosis of Alzheimer\u2019s disease using a combined algorithm incorporating clinical and novel biomarker data","volume":"6","author":"Sabbagh","year":"2017","journal-title":"Neurology and Therapy"},{"key":"10.1016\/j.pharmthera.2022.108119_bb7000","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2013.04.010","article-title":"Alzheimer's disease biomarkers: correspondence between human studies and animal models","volume":"56","author":"Sabbagh","year":"2013","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.pharmthera.2022.108119_bb2310","doi-asserted-by":"crossref","first-page":"10227","DOI":"10.1073\/pnas.92.22.10227","article-title":"Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40\/vector complex","volume":"92","author":"Saito","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2315","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.anorl.2011.03.002","article-title":"Anatomy and physiology of cerebrospinal fluid","volume":"128","author":"Sakka","year":"2011","journal-title":"European Annals of Otorhinolaryngology, Head and Neck Diseases"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2320","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1212\/WNL.0000000000012451","article-title":"Aducanumab, amyloid lowering, and slowing of Alzheimer disease","volume":"97","author":"Salloway","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2325","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-510X(02)00288-5","article-title":"Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease","volume":"203-204","author":"Salloway","year":"2002","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2330","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Salloway","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2335","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2340","doi-asserted-by":"crossref","DOI":"10.4161\/21688370.2014.985954","article-title":"Control of vascular permeability by adhesion molecules","volume":"3","author":"Sarelius","year":"2015","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2345","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2015.06.005","article-title":"Autonomic changes following generalized tonic clonic seizures: An analysis of adult and pediatric patients with epilepsy","volume":"115","author":"Sarkis","year":"2015","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2350","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0092-8674(91)90223-L","article-title":"PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model","volume":"64","author":"Sasahara","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2355","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2990.2012.01281.x","article-title":"Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: A possible hallmark of regenerative failure in Alzheimer's disease brains","volume":"39","author":"Satoh","year":"2013","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb8000","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40478-017-0429-5","article-title":"Taxifolin inhibits amyloid-\u03b2 oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy","volume":"5","author":"Saito","year":"2017","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108119_bb9000","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/jpet.116.237057","article-title":"Blood\u2013Brain Barrier Disruption and Neurovascular Unit Dysfunction in Diabetic Mice_ Protection with the Mitochondrial Carbonic Anhydrase Inhibitor Topiramate","volume":"359","author":"Salameh","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2360","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fnins.2015.00385","article-title":"Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives?","volume":"9","author":"Saunders","year":"2015","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2365","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00441-009-0821-y","article-title":"Proteoglycans: from structural compounds to signaling molecules","volume":"339","author":"Schaefer","year":"2010","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2370","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF02334602","article-title":"Alterations of the cerebral capillary bed in the senile dementia of Alzheimer","volume":"8","author":"Scheibel","year":"1987","journal-title":"Italian Journal of Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2375","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0197-4580(88)80014-9","article-title":"On the possible relationship of cortical microvascular pathology to blood brain barrier changes in Alzheimer\u2019s disease","volume":"9","author":"Scheibel","year":"1988","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2380","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00002093-198701000-00004","article-title":"Denervation microangiopathy in senile dementia, Alzheimer type","volume":"1","author":"Scheibel","year":"1987","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2385","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1987.1","article-title":"Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography","volume":"7","author":"Schlageter","year":"1987","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2395","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/PL00020042","article-title":"Serum-CSF protein gradients, the blood-GSF barrier and the local immune response","volume":"218","author":"Schliep","year":"1978","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2400","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF02890989","article-title":"Studien zur Pathologie der Hirngef\u00e4\u00dfe. II. Die drusige Entartung der Hirnarterien und Capillaren (eine Form seniler Gef\u00e4\u00dferkrankung)","volume":"162","author":"Scholz","year":"1938","journal-title":"Zeitschrift f\u00fcr die Gesamte Neurologie und Psychiatrie"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2405","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1523\/JNEUROSCI.2377-07.2008","article-title":"Immunotherapy reduces vascular amyloid-beta in PDAPP mice","volume":"28","author":"Schroeter","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10456-006-9030-4","article-title":"In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer\u2019s disease","volume":"9","author":"Schultheiss","year":"2006","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2415","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12728","article-title":"Amyloid-beta 1-40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro","volume":"17","author":"Schultz","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2420","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/NEN.0000000000000084","article-title":"Involvement of matrix metalloproteinase-9 in amyloid-beta 1-42-induced shedding of the pericyte proteoglycan NG2","volume":"73","author":"Schultz","year":"2014","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089970","article-title":"Impact of age on the cerebrovascular proteomes of wild-type and Tg-SwDI mice","volume":"9","author":"Searcy","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2430","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer\u2019s disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2435","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1017\/cjn.2016.296","article-title":"Microbleeds in Alzheimer\u2019s disease: a neuropsychological overview and meta-analysis","volume":"43","author":"Sepehry","year":"2016","journal-title":"The Canadian Journal of Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2440","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000112834","article-title":"Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mouse","volume":"5","author":"Seubert","year":"2008","journal-title":"Neurodegenerative Diseases"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2445","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2450","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1038\/s41598-020-64334-4","article-title":"Enhanced cerebral blood volume under normobaric hyperoxia in the J20-hAPP mouse model of Alzheimer\u2019s disease","volume":"10","author":"Shabir","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2455","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3174\/ajnr.A4176","article-title":"Cerebral microbleeds: different prevalence, topography, and risk factors depending on dementia diagnosis-the Karolinska Imaging Dementia Study","volume":"36","author":"Shams","year":"2015","journal-title":"AJNR. American Journal of Neuroradiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2460","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146379","article-title":"Chronic cerebral hypoperfusion alters amyloid-beta transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse","volume":"1723","author":"Shang","year":"2019","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2465","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-151126","article-title":"Strong impact of chronic cerebral hypoperfusion on neurovascular unit, cerebrovascular remodeling, and neurovascular trophic coupling in Alzheimer's disease model mouse","volume":"52","author":"Shang","year":"2016","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2470","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1177\/0271678X16660983","article-title":"Intracerebral GM-CSF contributes to transendothelial monocyte migration in APP\/PS1 Alzheimer\u2019s disease mice","volume":"36","author":"Shang","year":"2016","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2475","article-title":"Neurovascular coupling preserved in a chronic mouse model of Alzheimer\u2019s disease: Methodology is critical","volume":"271678X19890830","author":"Sharp","year":"2019","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2480","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuroscience.2019.07.050","article-title":"Chronic cerebral hypoperfusion activates the coagulation and complement cascades in Alzheimer's disease mice","volume":"416","author":"Shi","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2485","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/brain\/awm156","article-title":"Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy","volume":"130","author":"Shin","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2490","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104833","article-title":"Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer\u2019s patients","volume":"139","author":"Singh","year":"2020","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2495","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1126\/science.1691865","article-title":"Evidence that beta-amyloid protein in Alzheimer\u2019s disease is not derived by normal processing","volume":"248","author":"Sisodia","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2500","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jnnp.70.5.624","article-title":"Both total and phosphorylated tau are increased in Alzheimer\u2019s disease","volume":"70","author":"Sj\u00f6gren","year":"2001","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2505","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000048642","article-title":"Decreased CSF-beta-amyloid 42 in Alzheimer\u2019s disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms","volume":"13","author":"Sj\u00f6gren","year":"2002","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2510","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000017250","article-title":"Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio","volume":"11","author":"Sjogren","year":"2000","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.06.028","article-title":"CSF\/serum albumin ratio in dementias: a cross-sectional study on 1861 patients","volume":"59","author":"Skillback","year":"2017","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2520","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.50.4.966","article-title":"A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer\u2019s disease and vascular dementia","volume":"50","author":"Skoog","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2525","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1055\/s-0038-1665436","article-title":"Thrombin and its precursor in human cerebrospinal fluid","volume":"78","author":"Smirnova","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2530","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0308-2261(18)30021-3","article-title":"Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis","volume":"15","author":"Smith","year":"1986","journal-title":"Clinics in Haematology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2535","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","article-title":"Beta-amyloid, blood vessels, and brain function","volume":"40","author":"Smith","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2540","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.491","article-title":"Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity","volume":"8","author":"Song","year":"2017","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2545","first-page":"1","article-title":"Association of cardiovascular risk burden with risk of dementia and brain pathologies: A population-based cohort study","author":"Song","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2550","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","article-title":"Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model","volume":"10","author":"Spangenberg","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2555","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1971400916689483","article-title":"Assessment of cerebral microbleeds by susceptibility-weighted imaging in Alzheimer's disease patients: A neuroimaging biomarker of the disease","volume":"30","author":"Sparacia","year":"2017","journal-title":"The Neuroradiology Journal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2560","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","article-title":"Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier","volume":"33","author":"St-Amour","year":"2013","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2565","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pscychresns.2008.04.003","article-title":"Blood-brain barrier permeability in Alzheimer\u2019s disease: a case-control MRI study","volume":"171","author":"Starr","year":"2009","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2570","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","article-title":"Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging","volume":"74","author":"Starr","year":"2003","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2575","first-page":"734","article-title":"A morphometric study of the blood-brain barrier in Alzheimer\u2019s disease","volume":"67","author":"Stewart","year":"1992","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2580","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Sturchler-Pierrat","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2585","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0014-4886(03)00180-8","article-title":"P38 MAP kinase is activated at early stages in Alzheimer\u2019s disease brain","volume":"183","author":"Sun","year":"2003","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2590","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-2010-101023","article-title":"Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls","volume":"22","author":"Sundel\u00f6f","year":"2010","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2595","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2600","first-page":"192","article-title":"Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies","volume":"45","author":"Szpak","year":"2007","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2605","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004897","article-title":"Detrimental effects of centrally administered angiotensin II are enhanced in a mouse model of Alzheimer disease independently of blood pressure","volume":"6","author":"Takane","year":"2017","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2610","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.109.138586","article-title":"Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling","volume":"54","author":"Takeda","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2615","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","article-title":"Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease","volume":"88","author":"Tebay","year":"2015","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2620","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00005072-196310000-00005","article-title":"The fine structure of neurofibrillary tangles in Alzheimer\u2019s disease","volume":"22","author":"Terry","year":"1963","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2625","first-page":"269","article-title":"Ultrastructural studies in Alzheimer\u2019s presenile dementia","volume":"44","author":"Terry","year":"1964","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2630","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2635","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1074\/jbc.M409876200","article-title":"Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R\/2N transgenic mice","volume":"280","author":"Terwel","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2640","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1073\/pnas.0813404106","article-title":"Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice","volume":"106","author":"Thakker","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2645","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/j.1582-4934.2008.00411.x","article-title":"Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer\u2019s disease","volume":"12","author":"Thal","year":"2008","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2655","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JAD-2006-10114","article-title":"Angiogenic proteins are expressed by brain blood vessels in Alzheimer\u2019s disease","volume":"10","author":"Thirumangalakudi","year":"2006","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2660","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/brain\/awv025","article-title":"Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia","volume":"138","author":"Thomas","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2665","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1177\/0271678X17722436","article-title":"The vascular basement membrane in the healthy and pathological brain","volume":"37","author":"Thomsen","year":"2017","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2670","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2009.10.040","article-title":"Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency","volume":"210","author":"Tibolla","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2675","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","article-title":"Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols","volume":"10","author":"Tofts","year":"1999","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2680","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/01.STR.27.11.2069","article-title":"Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients","volume":"27","author":"Tomimoto","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2685","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3233\/JAD-161266","article-title":"Are major dementias triggered by poor blood flow to the brain? Theoretical considerations","volume":"57","author":"de la Torre","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2690","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-007-9579-2","article-title":"Fibrinogen induces endothelial cell permeability","volume":"307","author":"Tyagi","year":"2008","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2695","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-150642","article-title":"Intracerebroventricular infusion of angiotensin-(1-7) ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's disease","volume":"53","author":"Uekawa","year":"2016","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2700","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s004010050609","article-title":"Age-related changes in the brain transfer of blood-borne horseradish peroxidase in the hippocampus of senescence-accelerated mouse","volume":"93","author":"Ueno","year":"1997","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2705","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0167-4943(93)90035-G","article-title":"Age-related changes in barrier function in mouse brain I. Accelerated age-related increase of brain transfer of serum albumin in accelerated senescence prone SAM-P\/8 mice with deficits in learning and memory","volume":"16","author":"Ueno","year":"1993","journal-title":"Archives of Gerontology and Geriatrics"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2710","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jemt.1088","article-title":"Ultrastructural and permeability features of microvessels in the periventricular area of senescence-accelerated mice (SAM)","volume":"53","author":"Ueno","year":"2001","journal-title":"Microscopy Research and Technique"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2715","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3174\/ajnr.A3332","article-title":"Prevalence and topography of small hypointense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia","volume":"34","author":"Uetani","year":"2013","journal-title":"AJNR. American Journal of Neuroradiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2720","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/sj.jcbfm.9600148","article-title":"VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1","volume":"25","author":"Valable","year":"2005","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2725","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijdevneu.2008.10.002","article-title":"Time-course of blood-brain barrier disruption in senescence-accelerated mouse prone 8 (SAMP8) mice","volume":"27","author":"del Valle","year":"2009","journal-title":"International Journal of Developmental Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2735","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbr.2009.12.047","article-title":"The cerebrovascular role of the cholinergic neural system in Alzheimer\u2019s disease","volume":"221","author":"Van Beek","year":"2011","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2740","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1460-9568.2003.02444.x","article-title":"Age-dependent cognitive decline in the APP23 model precedes amyloid deposition","volume":"17","author":"Van Dam","year":"2003","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2745","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0002-9440(10)64644-5","article-title":"Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons","volume":"157","author":"Van Dorpe","year":"2000","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2750","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.18632\/aging.101869","article-title":"mTOR in cerebrovascular disease","volume":"11","author":"Van Skike","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2755","doi-asserted-by":"crossref","first-page":"H693","DOI":"10.1152\/ajpheart.00570.2017","article-title":"Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer\u2019s disease and vascular cognitive impairment","volume":"314","author":"Van Skike","year":"2018","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2760","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2353\/ajpath.2008.071191","article-title":"Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy","volume":"173","author":"Van Vickle","year":"2008","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2765","article-title":"Symptomatic amyloid-related imaging abnormalities in an APOE epsilon4\/epsilon4 patient treated with aducanumab","volume":"12","author":"VandeVrede","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2770","doi-asserted-by":"crossref","first-page":"13376","DOI":"10.1523\/JNEUROSCI.2788-07.2007","article-title":"Experimental investigation of antibody-mediated clearance mechanisms of amyloid-beta in CNS of Tg-SwDI transgenic mice","volume":"27","author":"Vasilevko","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2775","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-020-00211-2","article-title":"Increase in blood-brain barrier leakage in healthy, older adults","author":"Verheggen","year":"2020","journal-title":"Geroscience."},{"key":"10.1016\/j.pharmthera.2022.108119_bb2780","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1212\/01.wnl.0000307750.41970.d9","article-title":"Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study","volume":"70","author":"Vernooij","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2785","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1535-7511.2009.01312.x","article-title":"Leukocyte-endothelial adhesion mechanisms in epilepsy: cheers and jeers","volume":"9","author":"Vezzani","year":"2009","journal-title":"Epilepsy Currents"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2790","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2011.09.049","article-title":"Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort","volume":"505","author":"Viggars","year":"2011","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2795","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.STR.18.2.311","article-title":"Cerebral amyloid angiopathy. A critical review","volume":"18","author":"Vinters","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2800","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1528-1167.2012.03513.x","article-title":"Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation","volume":"53","author":"van Vliet","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2805","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/epi.13245","article-title":"Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats II: Potential mechanisms","volume":"57","author":"van Vliet","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2810","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","article-title":"Intersection of pathological tau and microglia at the synapse","volume":"7","author":"Vogels","year":"2019","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2815","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neurobiolaging.2008.08.005","article-title":"Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe\/PS1deltaE9-deleted transgenic mice model of ss-amyloidosis","volume":"31","author":"Volianskis","year":"2010","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2820","first-page":"258","article-title":"Effect of seizures on progression of dementia of the Alzheimer type","volume":"6","author":"Volicer","year":"1995","journal-title":"Dementia"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2825","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2830","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.24794","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease","volume":"80","author":"Vossel","year":"2016","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2835","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer\u2019s disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2840","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2169\/internalmedicine.37.509","article-title":"Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio","volume":"37","author":"Wada","year":"1998","journal-title":"Internal Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2845","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/00207454.2013.825258","article-title":"The potential mechanisms of Abeta-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease","volume":"124","author":"Wan","year":"2014","journal-title":"The International Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2850","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship between amyloid-beta deposition and blood-brain barrier dysfunction in Alzheimer's disease","volume":"15","author":"Wang","year":"2021","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2855","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jmri.20669","article-title":"Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls","volume":"24","author":"Wang","year":"2006","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2860","article-title":"Interleukin-1beta induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2865","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1096\/fj.03-1040fje","article-title":"Glypican-1 as an Abeta binding HSPG in the human brain: Its localization in DIG domains and possible roles in the pathogenesis of Alzheimer\u2019s disease","volume":"18","author":"Watanabe","year":"2004","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2870","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.7150\/thno.36718","article-title":"Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Weber-Adrian","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2875","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1523\/JNEUROSCI.15-04-02906.1995","article-title":"Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA","volume":"15","author":"Weinstein","year":"1995","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2880","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","article-title":"Pathophysiological consequences of VEGF-induced vascular permeability","volume":"437","author":"Weis","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2885","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/143908","article-title":"Blood-brain barrier dysfunction in epileptogenesis of the temporal lobe","volume":"2011","author":"Weissberg","year":"2011","journal-title":"Epilepsy Research and Treatment"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2890","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.02.029","article-title":"Albumin induces excitatory synaptogenesis through astrocytic TGF-beta\/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction","volume":"78","author":"Weissberg","year":"2015","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2895","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"22","author":"Westerman","year":"2002","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2900","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.neuroscience.2009.01.023","article-title":"Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer\u2019s disease","volume":"159","author":"Wilcock","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2905","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2353\/ajpath.2007.070050","article-title":"Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells","volume":"171","author":"Wilhelmus","year":"2007","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2910","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1523\/JNEUROSCI.21-05-01619.2001","article-title":"Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy","volume":"21","author":"Winkler","year":"2001","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059586","article-title":"Neuroinflammation and neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer\u2019s disease","volume":"8","author":"Wright","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2920","doi-asserted-by":"crossref","first-page":"eaax6646","DOI":"10.1126\/sciadv.aax6646","article-title":"Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer\u2019s disease","volume":"6","author":"Xhima","year":"2020","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2925","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4103\/0366-6999.162507","article-title":"Reduction of Glucose Metabolism in Olfactory Bulb is an Earlier Alzheimer\u2019s Disease-related Biomarker in 5XFAD Mice","volume":"128","author":"Xiao","year":"2015","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2930","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13020-020-00314-0","article-title":"Fish oil protects the blood-brain barrier integrity in a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Xie","year":"2020","journal-title":"Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2935","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/ptr.6849","article-title":"Lychee seed polyphenol protects the blood-brain barrier through inhibiting Abeta(25-35)-induced NLRP3 inflammasome activation via the AMPK\/mTOR\/ULK1-mediated autophagy in bEnd.3 cells and APP\/PS1 mice","volume":"35","author":"Xiong","year":"2021","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2940","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuroscience.2007.01.043","article-title":"Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice","volume":"146","author":"Xu","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2945","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/svn-2018-000198","article-title":"Basement membrane and blood-brain barrier","volume":"4","author":"Xu","year":"2019","journal-title":"Stroke and Vascular Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2950","article-title":"Blocking retrograde axonal transport of autophagosomes contributes to sevoflurane-induced neuron apoptosis in APP\/PS1 mice","author":"Xu","year":"2020","journal-title":"Acta Neurologica Belgica"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2955","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000343491","article-title":"Elevated plasma endothelial microparticles in Alzheimer's disease","volume":"34","author":"Xue","year":"2012","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2960","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0006-8993(88)90671-3","article-title":"Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P\/8 as an animal model of disturbances in recent memory","volume":"474","author":"Yagi","year":"1988","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2965","first-page":"79","article-title":"Vascular changes in the brains with Alzheimer's disease","volume":"45","author":"Yamashita","year":"1991","journal-title":"The Japanese Journal of Psychiatry and Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2970","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/awz011","article-title":"Selective loss of cortical endothelial tight junction proteins during Alzheimer\u2019s disease progression","volume":"142","author":"Yamazaki","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2975","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neurobiolaging.2014.08.005","article-title":"Blockage of GSK3beta-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer\u2019s disease","volume":"36","author":"Yan","year":"2015","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2980","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/STROKEAHA.115.008582","article-title":"Minocycline reduces spontaneous hemorrhage in mouse models of cerebral amyloid angiopathy","volume":"46","author":"Yan","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2985","doi-asserted-by":"crossref","first-page":"8928530","DOI":"10.1155\/2016\/8928530","article-title":"ATP induces disruption of tight junction proteins via IL-1 beta-dependent MMP-9 activation of human blood-brain barrier in vitro","volume":"2016","author":"Yang","year":"2016","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2990","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1212\/WNL.0000000000000285","article-title":"Incidence of cerebral microbleeds in preclinical Alzheimer disease","volume":"82","author":"Yates","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb2995","first-page":"F524","article-title":"A role for intracellular calcium in tight junction reassembly after ATP depletion-repletion","volume":"277","author":"Ye","year":"1999","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3000","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12035-019-01697-4","article-title":"Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer\u2019s Disease","volume":"57","author":"Yuan","year":"2020","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/WAD.0000000000000178","article-title":"Cognitive impairment and dementia in older adults with chronic kidney disease: A review","volume":"30","author":"Zammit","year":"2016","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.3913","article-title":"Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin","volume":"21","author":"Zenaro","year":"2015","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamaneurol.2016.4370","article-title":"Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains","volume":"74","author":"Zeppenfeld","year":"2017","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3020","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph0212s68","article-title":"Arrestin-3-dependent activation of c-Jun N-terminal kinases (JNKs)","volume":"68","author":"Zhan","year":"2015","journal-title":"Current Protocols in Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3025","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/ene.13030","article-title":"Association of serum vascular endothelial growth factor levels and cerebral microbleeds in patients with Alzheimer\u2019s disease","volume":"23","author":"Zhang","year":"2016","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0022-510X(94)90057-4","article-title":"Astrocytes in Alzheimer\u2019s disease express immunoreactivity to the vaso-constrictor endothelin-1","volume":"122","author":"Zhang","year":"1994","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10571-014-0127-9","article-title":"From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration","volume":"35","author":"Zhao","year":"2015","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3040","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.3390\/jcm10173795","article-title":"Caveolae-mediated endothelial transcytosis across the blood-brain barrier in acute Ischemic stroke","volume":"10","author":"Zhou","year":"2021","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1471-4159.2001.00046.x","article-title":"Activation and redistribution of c-jun N-terminal kinase\/stress activated protein kinase in degenerating neurons in Alzheimer\u2019s disease","volume":"76","author":"Zhu","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2022.108119_bb3050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","article-title":"Microvascular injury and blood-brain barrier leakage in Alzheimer\u2019s disease","volume":"28","author":"Zipser","year":"2007","journal-title":"Neurobiology of Aging"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:21:07Z","timestamp":1759011667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":609,"alternative-id":["S0163725822000134"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108119","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-brain barrier leakage in Alzheimer\u2019s disease: From discovery to clinical relevance","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108119"}}